Showing results (401-410 of 466) with videos related to
Sort By:
Pageof 47
The Pediatric Infectious Disease Journal|July 1, 1987
Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trialM G Bergeron, G Ahronheim, J E Richard, et al.Chemistry and Physics of Lipids|September 1, 1985
Role of sterol carrier protein in cholesterol metabolismM E Dempsey, P S Hargis, D M McGuire, et al.FEBS Letters|June 18, 2005
Expression of pro-apoptotic Bfk isoforms reduces during malignant transformation in the human gastrointestinal tractClare E Dempsey, Caroline Dive, Daniel J Fletcher, et al.Asia-Pacific Journal of Public Health|July 17, 2013
Fish intake by adolescents is related to nutrient intake but not lifestyle factorsLaila Rahman, Claudio R Nigg, Lee S Rosner, et al.Cell Transplantation|November 22, 2014
Human umbilical cord blood cells induce neuroprotective change in gene expression profile in neurons after ischemia through activation of Akt pathwayM D Shahaduzzaman, Vijay Mehta, Jason E Golden, et al.Journal of Pharmacy Practice|July 13, 2023
Effect of Alternatives to Opiates Program on Discharge Opioid Prescribing in Trauma PatientsSteven F Nerenberg, Caitlin E Kulig, Alexis M LaPietra, et al.Journal of the American Heart Association|April 26, 2015
hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradineDario Melgari, Kieran E Brack, Chuan Zhang, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|October 14, 2016
International variations in application of the best-interest standard across the age spectrumN Laventhal, A A E Verhagen, T W R Hansen, et al.The American Surgeon|April 20, 2021
Opioid Prescribing at Discharge in Opioid-Naïve Trauma PatientsJackie P Johnston, Alexis M LaPietra, Osama A Elsawy, et al.Journal of Pediatric Hematology/Oncology|August 13, 1999
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Yanofsky, S Pritchard, et al.Pageof 47